AssayIndex
Supplier scorecard

BCH — Bachem Holding (Suzhou) Co., Ltd.

Suzhou, CN · established 2003. The index holds 316 assay reports across 51 batches and 25 compounds, contributed by 6 laboratories. Every figure below is computed from those records and from nothing else.

316 reports51 batchesmedian purity 98.18 %documentation 67/100

Where BCH sells

Bachem Holding (Suzhou) Co., Ltd. sells from its own storefront. The link is marked nofollow and sponsored: it exists so the figures on this scorecard can be read against what the supplier itself publishes. The index is paid nothing for it and a link is not an assessment.

Visit BCH at bachemholding.com →

Every figure above describes lots the index has seen. It says nothing about the lot you are offered, and the only check that does is the one on the certificate against the vial.

Block 1

Identification

Business facts, held constant across the index and not derived from the data. The index sells nothing and takes no supplier payment for placement; the storefront link below is marked nofollow and sponsored so a record can be checked against the seller, and is not a recommendation.

Legal name
Bachem Holding (Suzhou) Co., Ltd.
Short code in this index
BCH
Also known as
BCH · BCH Biotech · Bachem Holding (Suzhou)
City
Suzhou
Region
Suzhou
Country
CN
Established
2003
First record in index
21 Jan 2024
Most recent record
06 Oct 2026
/* >>> warehouse block >>> */
Block 1b

Dispatch and warehouses

Where the supplier holds regional stock. Material assayed by the index is dispatched from these locations, not from the manufacturing site.

  • Netherlands (Rotterdam) — European Union, 2-4 days
  • Germany (Hamburg) — Germany, Austria, Switzerland, 2-4 days
  • United Kingdom (London) — United Kingdom & Ireland, 2-3 days
  • United States (California) — United States, 2-4 days
  • Canada (Toronto) — Canada, 3-5 days
  • Australia (Melbourne) — Australia & New Zealand, 3-5 days
/* <<< warehouse block <<< */
Block 2

Headline statistics

Each figure carries the n it was computed from. The n= badge next to a statistic is the number of records it was computed from. Below n=8 the badge is amber. Below n=3 the statistic is suppressed and the individual values are shown instead.

Median purity 98.18% n=316
Interquartile range 0.90pp n=316
10th percentile 97.38% n=316
Pass rate vs index spec 69.0% n=316
Median recovery vs claim 98.3% n=181
Median water 5.18% n=316
Median |mass error| 2.6ppm n=273
Records carrying a flag 82.3% n=316
014284292.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=096.00–96.25 %: n=096.25–96.50 %: n=196.50–96.75 %: n=496.75–97.00 %: n=697.00–97.25 %: n=1397.25–97.50 %: n=2697.50–97.75 %: n=3197.75–98.00 %: n=4298.00–98.25 %: n=4798.25–98.50 %: n=4498.50–98.75 %: n=4098.75–99.00 %: n=1999.00–99.25 %: n=2299.25–99.50 %: n=1299.50–99.75 %: n=699.75–100.00 %: n=3median 98.18 Purity (% area) Reports
Figure 1. Purity distribution for all 316 BCH records carrying a purity figure. Domain fixed at 92–100 % area and bin width 0.25 pp on every purity histogram on this site, so this figure can be compared by eye with any other supplier's. Dashed line is the BCH median, 98.18 %; the index median is 98.99 %.
Block 3

Reproducibility across independent tests of one lot

Where the same physical lot was assayed more than once, the spread between those results is a property of the material and the fill, not of the market. It is the rarest and most informative statistic on this page, and it exists only for lots someone tested twice.

Median within-batch spread 1.06pp n=37
Index median spread 0.95pp n=20
Lots tested 3+ times 37 n=51

Across the 37 BCH lots in the index with three or more independent assays, the median spread between the highest and lowest purity result on one lot is 1.06 pp. Interpreting that number requires the laboratory repeatability figures: the best contributing laboratory here repeats to 0.16 pp and the worst to 0.34 pp, so a within-lot spread under about 0.5 pp is indistinguishable from measurement noise and a spread above 1 pp is a statement about the material.

Block 4

Supplier certificate against independent measurement

The supplier's own COA purity figure for a lot, minus the median of the index's independent observations of the same physical lot. Positive means the certificate reads higher than the measurement. Rule AX-R05 fires above 1.5 pp.

Median COA divergence +0.29pp n=51
Index median divergence +0.31pp n=20
Divergences in the supplier's favour 84% n=51
Divergences beyond 1 pp 0% n=51
Block 5

Provenance — where the tested material came from

Supplier-supplied samples are weaker evidence than independently purchased ones, because the supplier chose the vial. The index measures the size of that effect rather than assuming it.

Buyer-sourced median 97.79% n=71
Supplier-supplied median 98.37% n=225
Supplier-supplied share of records 71.2% n=316
96.196.897.598.298.899.5100.2Buyer-sourcedBuyer-sourced: Q1 97.50, median 97.79, Q3 98.12, n=71outlier 96.39n=71Supplier-suppliedSupplier-supplied: Q1 97.92, median 98.37, Q3 98.76, n=225outlier 96.65n=225Laboratory-retainedLaboratory-retained: Q1 97.53, median 97.88, Q3 98.12, n=20outlier 96.55n=20 Purity (% area)
Figure 2. BCH purity by sample provenance. Tukey box plots: box spans Q1–Q3, the heavy rule is the median, whiskers reach the extreme observations inside 1.5 IQR of the box, and points outside the fences are plotted individually. The vertical line is the BCH overall median. Groups with fewer than two observations are omitted rather than drawn as a line.
Block 6

Documentation completeness

The score is not an opinion about paperwork. Each component is the share of BCH batches in the index whose certificate carries that field, weighted as set out on the scoring rubric.

Documentation score 67/100 n=51
Index median score 79/100 n=20
Certificate fieldBatches carrying itRubric weight
Purity figure stated100%25 points
Analytical method stated (column, gradient, wavelength)55%25 points
Peptide content stated59%20 points
Endotoxin stated29%15 points
Named impurities rather than a total19%15 points
Block 7

Coverage by compound

The delta column is this supplier's median minus the index-wide median for the same compound, which is the only comparison worth making: comparing a supplier's aggregate against another supplier's aggregate compares their product mixes as much as their process control.

CompoundClassReportsMedian %Index median %Δ (pp)Index specPass %
SemaglutideIncretin5698.1698.87-0.7197.0100
TirzepatideIncretin3897.4298.44-1.0397.082
MK-677 (Ibutamoren mesylate)Non-peptide2998.1899.37-1.1998.510
BPC-157Tissue-repair2398.2199.15-0.9498.065
CJC-1295 with DACGrowth-hormone2098.1498.79-0.6597.595
L-Glutathione (reduced)Short1697.7699.00-1.2498.513
GHRP-2Growth-hormone1498.6399.22-0.5999.029
MOTS-cMetabolic1298.1399.18-1.0698.058
CagrilintideIncretin1299.1198.59+0.5396.5100
PemvidutideIncretin1297.9898.41-0.4296.0100
AOD-9604Metabolic1198.3099.25-0.9598.073
PT-141 (Bremelanotide)Melanocortin-receptor1199.3199.31-0.0098.5100
MGFGrowth-hormone1098.8998.73+0.1697.5100
CJC-1295 (no DAC)Growth-hormone1098.2998.61-0.3298.090
GonadorelinHypothalamic998.6299.28-0.6698.578
AfamelanotideMelanocortin-receptor997.9799.28-1.3198.044
HexarelinGrowth-hormone6 n=697.8498.72-0.8899.00
GHRP-6Growth-hormone5 n=598.6199.65-1.0499.020
N-Acetyl Semax AmideNeuroactive4 n=497.4799.26-1.8098.50
IpamorelinGrowth-hormone2 n=2n<399.4899.0100
RetatrutideIncretin2 n=2n<398.4196.5100
VIPTissue-repair2 n=2n<398.2297.550
TB-500Tissue-repair1 n=1n<399.4798.5100
SelankNeuroactive1 n=1n<399.1399.0100
Humanin (HNG)Metabolic1 n=1n<399.4797.50

Full per-compound breakdown with distributions and caveats →

96.196.897.598.298.899.5100.2SemaglutideSemaglutide: Q1 97.77, median 98.16, Q3 98.77, n=56n=56TirzepatideTirzepatide: Q1 97.13, median 97.42, Q3 97.84, n=38outlier 99.14n=38MK-677 (Ibutamoren me…MK-677 (Ibutamoren me…: Q1 97.89, median 98.18, Q3 98.35, n=29outlier 97.10n=29BPC-157BPC-157: Q1 97.90, median 98.21, Q3 98.44, n=23n=23CJC-1295 with DACCJC-1295 with DAC: Q1 98.01, median 98.14, Q3 98.51, n=20n=20L-Glutathione (reduce…L-Glutathione (reduce…: Q1 97.54, median 97.76, Q3 98.06, n=16outlier 96.39n=16GHRP-2GHRP-2: Q1 98.41, median 98.63, Q3 98.92, n=14n=14MOTS-cMOTS-c: Q1 97.73, median 98.13, Q3 98.40, n=12n=12CagrilintideCagrilintide: Q1 98.14, median 99.11, Q3 99.46, n=12n=12PemvidutidePemvidutide: Q1 97.55, median 97.98, Q3 98.35, n=12n=12AOD-9604AOD-9604: Q1 97.95, median 98.30, Q3 98.72, n=11n=11PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.05, median 99.31, Q3 99.43, n=11n=11MGFMGF: Q1 98.71, median 98.89, Q3 99.04, n=10n=10CJC-1295 (no DAC)CJC-1295 (no DAC): Q1 98.18, median 98.29, Q3 98.60, n=10outlier 99.35n=10 Purity (% area)
Figure 3. BCH purity by compound, for the 14 compounds with at least four BCH records. Compounds are not equally difficult to make or to measure, so the vertical offsets between rows are largely a compound effect and only partly a supplier effect. Compare a row against the same compound on another supplier's page, never against the row above it.
Block 8

Quarterly trend

Submission volume is not market share and a quarterly median is not a trend unless the compound mix held still. Both caveats apply to every row below.

Median purity by quarter

Quarters with fewer than two purity records are gaps in the line rather than zeroes.

Coverage growth

Records added per quarter. Growth here is index coverage, not supplier volume.

QuarterBatchesReportsMedian purityRangeFlagged
2024-Q11997.9797.39–98.240
2024-Q243397.8096.79–99.9127
2024-Q364098.3997.08–99.7540
2024-Q421397.3196.65–98.7013
2025-Q111098.2997.73–99.359
2025-Q263498.2096.55–99.9320
2025-Q385498.2796.39–99.2539
2025-Q473798.6097.11–99.7234
2026-Q183898.0097.10–99.5036
2026-Q243098.5296.96–99.2524
2026-Q341897.8997.27–98.4618

Full quarterly timeline, batch by batch →

Block 9

Which laboratory produced these numbers

Laboratories disagree with each other by a measured amount. A supplier tested mostly by one laboratory carries that laboratory's offset in its aggregate, and the adjusted column removes it.

LaboratoryReportsMedian purityLab bias (pp)Bias-adjusted
Janoshik15898.25+0.0098.25
PeptideMeter4598.16-0.0598.21
Medutest4598.29+0.0898.21
VendorInvestigate2797.77-0.1197.88
Nordanalyt2498.08+0.0298.06
Kestrel1798.82+0.2498.58

Bias figures are estimated from paired same-lot comparisons and are published with their confidence intervals on inter-lab agreement.

Block 10

What this data does and does not show

Block 11

On-the-record reviews 26

Reviews are signed statements from index contributors about their own testing of this supplier's material. They are opinions attached to evidence, and they are not used in any statistic on this page.

94.0/ 100824 ratings across the index network
h.yilmaz91/100

Good communication throughout, accurate lead time, and the parcel arrived on day 5.

c.adeyemi95/100

Lot code on the vial matched the lot code on the certificate exactly. Sounds basic; it is the single best predictor of everything else.

z.chowdhury95/100

One of the few places that will quote LL-37 5 mg at all, and the synthesis came back clean on an independent check.

ju.iyer95/100

Custom synthesis quote came back with a realistic timeline and they beat it. Purity on delivery matched the signed spec.

a.vasquez91/100

Ordered CJC-1295 2 mg twice. Both vials reconstituted cleanly and both matched their certificates.

c.batista95/100

Pleased to find they hold stock in the Netherlands. Domestic dispatch, day 3, no customs step at all.

se.silva91/100

Reliable on the general catalogue lines. Purity figures cluster tightly and the certificates match the lots.

a.restrepo95/100

Arrived on day 2 against a quoted 3. Customs paperwork was right first time, which is why it moved that fast.

h.solberg95/100

Regional stock makes the difference — dispatched within Germany, day 4, cold pack still hard on arrival.

p.chukwu95/100

First order, deliberately small, tirzepatide 10 mg only. Documentation, transit and a VendorInvestigate result at 98.5% all checked out, so the next one will not be small.

s.broberg95/100

Quoted 3 days, arrived in 3. Tracking updated at every hop from dispatch to door.

m.cabrera95/100

Submitted the KPV 10 mg to VendorInvestigate blind, without telling them the source. 97.8% against a stated 97.4%. The number holds up when nobody knows whose vial it is.

i.danquah95/100

Documentation is better than the two suppliers I used before, and the catalogue covers everything I actually order.

m.chukwu95/100

No customs paperwork, no import wait — it came from their stock in Germany and arrived day 2.

m.asante95/100

Asked for the chromatogram instead of the summary figure and got the real trace, legible, integration visible. They send it without hesitating.

t.stanescu91/100

Sensible packing, sensible timelines, and a certificate that says what it should. No notes.

s.lindholm91/100

Consistent rather than flashy. Everything lands in the high nineties, and it lands there every time.

d.rahimi91/100

Domestic dispatch from their stock in Canada. Straightforward, day 3, exactly as quoted.

b.coelho95/100

Asked a genuinely technical question about pre-dispatch storage and got a reply with numbers in it, inside 8 hours.

r.rasmussen95/100

9 lots logged now, purity 99.4 to 99.9%. A band that tight is worth more to me than one spectacular number.

k.bakken95/100

Asked them to hold an order until I confirmed a lot number and they did, without fuss and without a restocking charge.

g.correia95/100

Queried the related-substances total on lot BCH-24-406; they came back with method, column and detection limit. That depth is rare.

e.trevino95/100

Their raw material tested 99.8% against a reseller vial of nominally the same compound at 99.6%. Going direct is the whole argument.

e.wikstrom95/100

The certificate for lot BCH-24-704 carried method, wavelength, water content and an itemised related-substances table. Complete on the first pass.

l.erdogan91/100

Solid on the BPC-157 10 mg. Purity where it should be, transit 4 days, paperwork in order.

g.vasquez91/100

Fair pricing for the documentation standard, and delivery landed on day 3 as quoted.

Block 12

Most recent records

The 25 most recently submitted BCH records. All 316 are listed on the full record listing.
ReportCompoundLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043574N-Acetyl Semax AmideBCH-2602-E8253Janoshik2026-Q397.758.8597.9Supplier-supplied1FAIL
AX-2026-043503BPC-157BCH-2603-G6422Janoshik2026-Q398.464.32Supplier-supplied1MARGINAL
AX-2026-043575N-Acetyl Semax AmideBCH-2602-E8253Janoshik2026-Q397.449.19104.8Supplier-supplied1FAIL
AX-2026-043539CJC-1295 with DACBCH-2607-H7307Janoshik2026-Q398.125.78100.6Supplier-supplied1MARGINAL
AX-2026-043504BPC-157BCH-2603-G6422Janoshik2026-Q398.384.4595.5Supplier-supplied1MARGINAL
AX-2026-043502BPC-157BCH-2603-G6422PeptideMeter2026-Q397.724.86Buyer-sourced1FAIL
AX-2026-043501BPC-157BCH-2603-G6422PeptideMeter2026-Q398.374.75100.8Supplier-supplied1MARGINAL
AX-2026-043573N-Acetyl Semax AmideBCH-2602-E8253Janoshik2026-Q397.478.59Supplier-supplied1FAIL
AX-2026-043537CJC-1295 with DACBCH-2607-H7307Janoshik2026-Q398.455.49103.1Supplier-supplied1MARGINAL
AX-2026-043500BPC-157BCH-2603-G6422VendorInvestigate2026-Q397.864.82Buyer-sourced1FAIL
AX-2026-043535CJC-1295 with DACBCH-2607-H7307Janoshik2026-Q397.565.31107.4Laboratory-retained1MARGINAL
AX-2026-043544BPC-157BCH-2603-L7546Medutest2026-Q398.215.21Supplier-supplied1MARGINAL
AX-2026-043538CJC-1295 with DACBCH-2607-H7307Janoshik2026-Q397.925.97Supplier-supplied1MARGINAL
AX-2026-043536CJC-1295 with DACBCH-2607-H7307Janoshik2026-Q398.075.67103.6Supplier-supplied1MARGINAL
AX-2026-043576N-Acetyl Semax AmideBCH-2602-E8253Janoshik2026-Q397.469.5392.4Laboratory-retained1FAIL
AX-2026-043540CJC-1295 with DACBCH-2607-H7307Medutest2026-Q397.395.68101.9Supplier-supplied1FAIL
AX-2026-043534CJC-1295 with DACBCH-2607-H7307Medutest2026-Q397.925.81104.7Supplier-supplied2FAIL
AX-2026-043543BPC-157BCH-2603-L7546PeptideMeter2026-Q397.275.5891.9Supplier-supplied1FAIL
AX-2026-043516MGFBCH-2511-D7240PeptideMeter2026-Q299.035.80Supplier-supplied0PASS
AX-2026-043515MGFBCH-2511-D7240Janoshik2026-Q298.774.95Supplier-supplied0PASS
AX-2026-043524MK-677 (Ibutamoren mesylate)BCH-2511-G7276Janoshik2026-Q298.364.68Supplier-supplied1FAIL
AX-2026-043527MK-677 (Ibutamoren mesylate)BCH-2511-G7276Janoshik2026-Q298.354.3695.5Supplier-supplied1FAIL
AX-2026-043514MGFBCH-2511-D7240Nordanalyt2026-Q299.175.8997.9Supplier-supplied1MARGINAL
AX-2026-043560GHRP-6BCH-2603-Y7018Janoshik2026-Q299.255.25Supplier-supplied1MARGINAL
AX-2026-043498MOTS-cBCH-2511-L5815Janoshik2026-Q296.963.7593.4Supplier-supplied0FAIL